Suggestions
Marcel Imwinkelried
Multi-Site Head Drug Product Operations bei Siegfried Holding AG
Marcel Imwinkelried is a seasoned pharmaceutical industry executive who currently serves as the CEO of Siegfried Holding AG, a position he assumed on September 1, 2024.23 Prior to becoming CEO, he held various leadership roles within the company, including:
- COO Drug Products / Member of the Executive Committee (October 2021 - August 2024)
- Multi-Site Head Drug Product Operations (January 2021 - September 2021)
Before joining Siegfried, Imwinkelried had an extensive career at Novartis and its subsidiaries, where he held several high-level positions1:
- Global Head Solids of Technical Operations at Novartis (2018-2020)
- Head of Technical Operations Eastern Europe, Turkey, India & Africa at Novartis (2016-2017)
- Head of Technical Operations Steriles & Special Technology at Sandoz (2013-2016)
- Head of Technical Operations Switzerland at Novartis (2009-2012)
Imwinkelried's educational background includes an Engineer's Degree in Chemical Engineering from Zentralschweizerisches Technikum in Horw and an Engineer's Degree in Economics from the University of St.Gallen.1
With nearly two decades of senior leadership experience in the pharmaceutical industry, Marcel Imwinkelried brings a wealth of knowledge and expertise to his role as CEO of Siegfried Holding AG.3
